Dr. Reddy's Pravastatin Tablets Recall: Impurity Risk in 10mg Tablets
Dr. Reddy's recalls 10mg Pravastatin tablets with high impurity levels that may cause health risks. Affected lots C700220 (expiring June 2018) in 90-count and 500-count bottles.
Recall notice
Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220.
Contact the company
What happened, in plain English
Dr. Reddy's is recalling 10mg Pravastatin Sodium Tablets due to impurities that could pose health risks. This affects specific lots of tablets sold in 90-count and 500-count bottles with expiration dates through June 2018. Read more at govinfonow.com/recall/41510-dr-reddy-s-pravastatin-tablets-recall-impurity-risk-in-10mg.
Source Summary by GovInfoNow · govinfonow.com/recall/41510-dr-reddy-s-pravastatin-tablets-recall-impurity-risk-in-10mg · Updated October 8, 2026 · FDA enforcement record: FDA #D-1038-2017
Cite this page
“Dr. Reddy's Pravastatin Tablets Recall: Impurity Risk in 10mg Tablets.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41510-dr-reddy-s-pravastatin-tablets-recall-impurity-risk-in-10mg. Based on FDA recall #D-1038-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1038-2017%22&limit=1).
Why it’s dangerous
The tablets contain high levels of impurities that may not be safe for consumption. This could lead to potential health issues for people taking the medication as prescribed.
Who’s affected
People who have the specific 10mg Pravastatin tablets with lot number C700220 (expiring June 2018) in 90-count or 500-count bottles. Those taking this medication for cholesterol management are most at risk.
How to tell if you have this one
Check for 10mg Pravastatin tablets in 90-count bottles (NDC 55111-229-90) or 500-count bottles (NDC 55111-229-05) with lot number C700220 and expiration date June 2018.
- Brand
Dr. Reddy's- Category
Drug
What to do — step by step
Check Your Medication
Look for the lot number C700220 on the bottle with expiration date June 2018.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 21 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Dr. Reddy's recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1038-2017 (July 11, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1038-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.